The chronic colitis developed by HLA-B27 transgenic rats is associated with altered In Vivo mucin synthesis

Digestive Diseases and Sciences

Volumn 49, Issue 2, 2004, Pages 339-346

  Faure, M ^a   Moennoz D ^a   Mettraux, C ^a   Montigon, F ^a   Schiffrin, E J ^a   Obled, C ^b   Breuille D ^a   Boza, J ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b CEMAGREF   (France)

Author keywords

Chronic colitis; HLA B27; IBD; Mucin; Rats; Synthesis

Indexed keywords

HLA B27 ANTIGEN; MESSENGER RNA; MUCIN; MUCIN 2; MUCIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CHRONIC DISEASE; COLITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; GOBLET CELL; IN VIVO STUDY; IRRITABLE COLON; JEJUNUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSGENIC ANIMAL;

AMINO ACIDS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CHRONIC DISEASE; COLITIS; COLON; HLA-B27 ANTIGEN; INTESTINAL MUCOSA; JEJUNUM; MALE; MUCINS; RATS; RATS, INBRED F344; RNA, MESSENGER;

EID: 12144289953     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000017462.75257.70     Document Type: Article

References (35)

1. Allen A: Structure and function of gastrointestinal mucus. In Physiology of the Gastrointestinal Tract. Ld R Johnson (ed). New York, Raven Press, 1981, pp 617-639
2. Neutra MR, Forstner JF: Gastrointestinal mucus: Synthesis, secretion and function. In Physiology of the Gastrointestinal Tract. Ld R Johnson (ed). New York, Raven Press, 1987, pp 975-1009
3. Van Klinken BJ, Dekker J, Buller HA, Einerhand AW: Mucin gene structure and expression: protection vs. adhesion. Am J Physiol 269:G613-G627, 1995
4. Albanese CT, Cardona M, Smith SD, Watkins S, Kurkchubasche AG, Ulman I, Simmons RL, Rowe MI: Role of intestinal mucus in transepithelial passage of bacteria across the intact ileum in vitro. Surgery 116:76-82, 1994
5. Jenkins RT, Ramage JK, Jones DB, Collins SM, Goodacre RL, Hunt RH: Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease. Clin Invest Med 11:151-155, 1988
6. Arslan G, Atasever T, Cindoruk M, Yildirim IS: (51)CrEDTA colonic permeability and therapy response in patients with ulcerative colitis. Nucl Med Commun 22:997-1001, 2001
7. Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S, Pignatelli M: Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 47:589-594, 2000
8. Filipe MI: Mucins in the human gastrointestinal epithelium: a review. Invest Cell Pathol 2:195-216, 1979
9. McCormick DA, Horton LW, Mee AS: Mucin depletion in inflammatory bowel disease. J Clin Pathol 43:143-146, 1990
10. Pullan RD, Thomas GA, Rhodes M, Newcombe RG, Williams GT, Allen A, Rhodes J: Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 35:353-359, 1994
11. Theodossi A, Spiegelhalter DJ, Jass J, Firth J, Dixon M, Leader M, Levison DA, Lindley R, Filipe I: Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut 35:961-968, 1994
12. Tytgat KM. Van der Wal JW, Einerhand AW, Buller HA, Dekker J: Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem Biophys Res Commun 224:397-405, 1996
13. Jacobs LR, Huber PW: Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases. J Clin Invest 75:112-118, 1985
14. Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, Porchet N, Aubert JP: Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 49:544-551, 2001
15. Weiss AA, Babyatsky MW, Ogata S, Chen A, Itzkowitz SH: Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J Histochem Cytochem 44:1161-1166, 1996
16. Elson CO, Sartor RB, Tennyson GS, Riddell RH: Experimental models of inflammatory bowel disease. Gastroenterology 109:1344-1367, 1995
17. Fedorak RN: Naturally occuring and experimental models of inflammatory bowel disease. In Inflammatory Bowel Disease. BK Joseph (ed). Baltimore, Williams, and Wilkins, 1995, pp 71-95
18. Pizarro TT, Arseneau KO, Bamias G, Cominelli F: Mouse models for the study of Crohn's disease. Trends Mol Med 9:218-222, 2003
19. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD: Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63:1099-1112, 1990
20. Taurog JD, Maika SD, Simmons WA, Breban M, Hammer RE: Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 150:4168-4178, 1993
21. Aiko S, Grisham MB: Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology 109:142-150, 1995
22. Sartor RB: Colitis in HLA-B27/beta 2 microglobulin transgenic rats. Int Rev Immunol 19:39-50, 2000
23. Hata K, Andoh A, Sato H, Araki Y, Tanaka M, Tsujikawa T, Fujiyama Y, Bamba T: Sequential changes in luminal microflora and mucosal cytokine expression during developing of colitis in HLA-B27/beta2-microglobulin transgenic rats. Scand J Gastroenterol 36:1185-1192, 2001
24. Breban M: HLA-B27 transgenic rats model. Ann Med Interne (Paris) 149:139-141, 1998
25. Mercier S, Breuille D, Mosoni L, Obled C, Patureau MP: Chronic inflammation alters protein metabolism in several organs of adult rats. J Nutr 132:1921-1928, 2002
26. El Yousfi K, Breuille D, Papet I, Blum S, André M, Mosoni L, Denis P, Buffière C, Obled C: Increased tissue protein synthesis during spontaneous colitis in HLA-B27 rats implies different underlying mechanisms. Clin Sci (Lond) 105:437-446, 2003
27. Faure M, Moennoz D, Montigon F, Mettraux C, Mercier S, Schiffrin EJ, Obled C, Breuille D, Boza J: Mucin production and composition is altered in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci 48:1366-1373, 2003
28. Garlick PJ, McNurlan MA, Preedy VR: A rapid and convenient technique for measuring the rate of protein synthesis in tissues by injection of [3H]phenylalanine. Biochem J 192:719-723, 1980
29. Faure M, Moennoz D, Montigon F, Fay LB, Breuillé D, Finot PA, Ballevre O, Boza J: Development of a rapid and convenient method to purify mucins and determine their in vivo synthesis rate in rats. Anal Biochem 307:244-251, 2002
30. Breuille D, Rose F, Arnal M, Melin C, Obled C: Sepsis modifies the contribution of different organs to whole-body protein synthesis in rats. Clin Sci(Lond) 86:663-669, 1994
31. Lin J, Ho S, Shekels L, Paparella MM, Kim Y: Mucin gene expression in the rat middle ear: an improved method for RNA harvest. Ann Otol Rhinol Laryngol 108:762-768, 1999
32. Borchers MT, Wesselkamper S, Wert SE, Shapiro SD, Leikauf GD: Monocyte inflammation augments acrolein-induced Muc5ac expression in mouse lung. Am J Physiol 277:L489-L497, 1999
33. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Jr., Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB: Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 98:945-953, 1996
34. Goldspink DF, Lewis SE, Kelly FJ: Protein synthesis during the developmental growth of the small and large intestine of the rat. Biochem J 217:527-534, 1984
35. Laurichesse H, Tauveron I, Gourdon F, Cormerais L, Champredon C, Charrier S, Rochon C, Lamain S, Bayle G, Laveran H, Thieblot P, Beytout J, Grizard J: Threonine and methionine are limiting amino acids for protein synthesis in patients with AIDS. J Nutr 128:1342-1348, 1998